Dr Darius McPhail
Teams and roles for Darius McPhail
Research Fellow
Biomedicine Department
Publication
2025
- McPhail, D. K. et al. 2025. Loss of tuberous sclerosis complex 2 confers inflammation via dysregulation of nuclear factor kappa-light-chain-enhancer of activated B cells. Journal of Inflammation 22 (1) 38. (10.1186/s12950-025-00464-8)
- Tahsin, T. et al., 2025. Targeting NRF2 and FSP1 to overcome ferroptosis resistance in TSC2-deficient and cancer cells. Cancers 17 (16) 2714. (10.3390/cancers17162714)
2023
- McPhail, D. 2023. Targeting neuroinflammation in mTORC1 driven brain tumours. PhD Thesis , Cardiff University.
2020
- Friguglietti, J. et al., 2020. Novel silicon titanium diboride micropatterned substrates for cellular patterning. Biomaterials 244 119927. (10.1016/j.biomaterials.2020.119927)
Articles
- McPhail, D. K. et al. 2025. Loss of tuberous sclerosis complex 2 confers inflammation via dysregulation of nuclear factor kappa-light-chain-enhancer of activated B cells. Journal of Inflammation 22 (1) 38. (10.1186/s12950-025-00464-8)
- Tahsin, T. et al., 2025. Targeting NRF2 and FSP1 to overcome ferroptosis resistance in TSC2-deficient and cancer cells. Cancers 17 (16) 2714. (10.3390/cancers17162714)
- Friguglietti, J. et al., 2020. Novel silicon titanium diboride micropatterned substrates for cellular patterning. Biomaterials 244 119927. (10.1016/j.biomaterials.2020.119927)
Thesis
- McPhail, D. 2023. Targeting neuroinflammation in mTORC1 driven brain tumours. PhD Thesis , Cardiff University.